These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SEN virus does not affect treatment response in hepatitis C virus coinfected patients but SEN virus response depends on SEN virus DNA concentration. Sagir A, Adams O, Kirschberg O, Erhardt A, Heintges T, Haussinger D. World J Gastroenterol; 2004 Jul 01; 10(13):1893-7. PubMed ID: 15222031 [Abstract] [Full Text] [Related]
3. SEN Virus infection in HIV/HCV coinfected patients. Sagir A, Adams O, Oette M, Vogel M, Kupfer B, Emmelkamp J, Rockstroh J, Häussinger D. Eur J Med Res; 2008 Nov 24; 13(11):495-9. PubMed ID: 19073384 [Abstract] [Full Text] [Related]
5. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C. Umemura T, Alter HJ, Tanaka E, Orii K, Yeo AE, Shih JW, Matsumoto A, Yoshizawa K, Kiyosawa K. Hepatology; 2002 Apr 24; 35(4):953-9. PubMed ID: 11915044 [Abstract] [Full Text] [Related]
9. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. N Engl J Med; 2002 Sep 26; 347(13):975-82. PubMed ID: 12324553 [Abstract] [Full Text] [Related]
10. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C. Martin-Carbonero L, Nuñez M, Mariño A, Alcocer F, Bonet L, García-Samaniego J, López-Serrano P, Cordero M, Portu J, Soriano V. AIDS; 2008 Jan 02; 22(1):15-21. PubMed ID: 18090387 [Abstract] [Full Text] [Related]
12. Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C. Rigas B, Hasan I, Rehman R, Donahue P, Wittkowski KM, Lebovics E. Lancet; 2001 Dec 08; 358(9297):1961-2. PubMed ID: 11747922 [Abstract] [Full Text] [Related]
13. Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis C. Núnez M, Camino N, Ramos B, Berdún MA, Barreiro P, Losada E, Santos I, Echevarría S, Ocampo A, Miralles C, Arazo P, Martín-Carbonero L, Romero M, García-Samaniego J, Soriano V. Antivir Ther; 2005 Dec 08; 10(5):657-62. PubMed ID: 16152759 [Abstract] [Full Text] [Related]
16. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin. Gallegos-Orozco JF, Fuentes AP, Olivera-Martinez MA, Gutiérrez-Reyes G, Cortina D, Oregel JA, Pérez-Pruna C, Sixtos MS, Cruz-Castellanos S, Soto-Ramírez LE, Rodríguez-Díaz R, Fuentes-Romero L, Gutiérrez-Ruiz MC, Kershenobich D. Rev Invest Clin; 2003 Dec 08; 55(2):138-42. PubMed ID: 12827916 [Abstract] [Full Text] [Related]
17. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C. Di Bisceglie AM, Ghalib RH, Hamzeh FM, Rustgi VK. J Viral Hepat; 2007 Oct 08; 14(10):721-9. PubMed ID: 17875007 [Abstract] [Full Text] [Related]
18. Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1. Hui CK, Yuen MF, Sablon E, Chan AO, Wong BC, Lai CL. J Infect Dis; 2003 Apr 01; 187(7):1071-4. PubMed ID: 12660921 [Abstract] [Full Text] [Related]